Bios Equity COF

Director at Actuate Therapeutics · 1 reported transaction in 1 company · latest trade Jun 27, 2025

Their record

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +15.1%, S&P 500 +9.2% over the same days.


Actuate TherapeuticsACTU	Bought $500K · 71,428 shares	Jun 27, 2025	S&P 500 +22.9%thru Oct 30

Jun 27, 2025 · ACTU

$500K

S&P 500 +22.9%thru Oct 30

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.